RFC
IOVA icon

Regions Financial Corp’s Iovance Biotherapeutics IOVA Stock Holding History

Regions Financial Corp’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.7K Hold
12,660
– – ﹤0.01% 846
2026
Q1 		$44.4K Buy
12,660
+660
+6% +$2.11K ﹤0.01% 850
2025
Q4 		$32.8K Hold
12,000
– – ﹤0.01% 829
2025
Q3 		$26K Sell
12,000
-7,200
-38% -$17K ﹤0.01% 829
2025
Q2 		$33K Buy
+19,200
New +$47.8K ﹤0.01% 838

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Regions Financial Corp's IOVA Position: Q2 2026 in Review

Regions Financial Corp held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 12,660 shares worth $52.7K. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Regions Financial Corp first reported a position in IOVA in Q2 2025 and has held it in 5 quarters since. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Regions Financial Corp held 12,660 shares of Iovance Biotherapeutics worth $52.7K as of Q2 2026.
  • Regions Financial Corp left its Iovance Biotherapeutics share count unchanged in Q2 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #846 holding.
  • Regions Financial Corp first reported a position in Iovance Biotherapeutics in Q2 2025 and has held it in 5 quarters since.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.